home · filing · 0001868726-24-000031
8-K
filed May 6, 2024, 7:59 PM ET
ticker OLPX
CIK 0001868726
leadership
confidence high
sentiment neutral
materiality 0.60
Olaplex appoints Paul Kosturos as interim CFO after Eric Tiziani resigns
OLAPLEX HOLDINGS, INC.
Paul Kosturos appointed interim CFO effective May 6, 2024; succeeds Eric Tiziani who resigned same day.
Kosturos is a Managing Director at Alvarez & Marsal; engagement letter previously disclosed April 4, 2024.
No further details on Tiziani's departure or compensation terms in this filing.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2024-05-06
Filed May 6, 2024, 7:59 PM ET
appointed Paul Kosturos as interim Chief Financial Officer of the Company, effective May 6, 2024
Departed
Eric Tiziani
Chief Financial Officer
OLPX ·
OLAPLEX HOLDINGS, INC.
Effective 2024-05-06
Successor Paul Kosturos
Filed May 6, 2024, 7:59 PM ET
Mr. Kosturos succeeds Eric Tiziani, who resigned from his role as Chief Financial Officer of the Company, effective May 6, 2024
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Paul Kosturos was appointed as interim Chief Financial Officer at OLAPLEX HOLDINGS, INC..
Action appointed
Role interim Chief Financial Officer
Exact text from the filing
appointed Paul Kosturos as interim Chief Financial Officer of the Company, effective May 6, 2024
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Eric Tiziani resigned as Chief Financial Officer at OLAPLEX HOLDINGS, INC..
Action resigned
Role Chief Financial Officer
Exact text from the filing
Mr. Kosturos succeeds Eric Tiziani, who resigned from his role as Chief Financial Officer of the Company, effective May 6, 2024
View on SEC.gov
Source: SEC EDGAR
accession 0001868726-24-000031
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.